Trial Profile
A Randomized Controlled Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 03 Aug 2017 Status changed from not yet recruiting to discontinued.
- 01 Oct 2015 New trial record